Renaissance Technologies - AEGLEA BIOTHERAPEUTICS INC ownership

AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 96 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of AEGLEA BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$177
+234.0%
393,000
+117.0%
0.00%
Q1 2023$53
-22.1%
181,100
+19.9%
0.00%
Q4 2022$68
-99.9%
151,100
-39.5%
0.00%
Q3 2022$131,000
-55.4%
249,800
-57.1%
0.00%
Q2 2022$294,000
-15.8%
582,444
+283.5%
0.00%
Q1 2022$349,000
-70.4%
151,868
-38.8%
0.00%
-100.0%
Q4 2021$1,179,000
+47.9%
248,200
+147.5%
0.00%0.0%
Q3 2021$797,000
+125.8%
100,300
+97.5%
0.00%
Q2 2021$353,000
+325.3%
50,787
+383.7%
0.00%
Q1 2021$83,000
-78.6%
10,500
-78.7%
0.00%
Q4 2020$387,000
-84.3%
49,208
-85.8%
0.00%
-100.0%
Q3 2020$2,462,000
-52.0%
347,239
-37.3%
0.00%
-50.0%
Q2 2020$5,125,000
+83.4%
554,039
-7.6%
0.00%
+33.3%
Q1 2020$2,794,000
-36.5%
599,639
+4.1%
0.00%0.0%
Q4 2019$4,400,000
+2.0%
575,900
+2.7%
0.00%
-25.0%
Q3 2019$4,312,000
+15.5%
560,700
+2.9%
0.00%
+33.3%
Q2 2019$3,733,000
+2.2%
545,000
+20.1%
0.00%0.0%
Q1 2019$3,653,000
+6.8%
453,800
-0.6%
0.00%
-25.0%
Q4 2018$3,419,000
-23.5%
456,500
-2.3%
0.00%
-20.0%
Q3 2018$4,472,000
-32.2%
467,261
-25.9%
0.01%
+25.0%
Q2 2018$6,600,000
+552.2%
630,200
+517.8%
0.00%
+300.0%
Q1 2018$1,012,000
+481.6%
102,000
+217.8%
0.00%
Q4 2017$174,000
+176.2%
32,100
+150.8%
0.00%
Q3 2017$63,000
-35.1%
12,800
-49.2%
0.00%
Q2 2017$97,000
-64.1%
25,205
-30.4%
0.00%
Q1 2017$270,00036,2000.00%
Other shareholders
AEGLEA BIOTHERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Yu Fan 20,592$347,79824.67%
VR Adviser, LLC 295,034$3,614,1670.38%
IFP Advisors, Inc 2,860$1,7180.00%
View complete list of AEGLEA BIOTHERAPEUTICS INC shareholders